SEC Form 4 · accession 0001062993-15-001995
Protea Biosciences Group, Inc. · PRGB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Greg Kilby
Officer — Vice President, Operations · Other
Period of report
Apr 1, 2015
Accepted (ET)
Apr 15, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335103
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (call)F1 | $0.53 | Apr 1, 2015 | A | 150,000 | A | — | Apr 1, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The Stock Option vests in 37,500 share increments annually on each of the first four anniversaries of the date of grant beginning on April 1, 2016.